Page 37 - Программа - Всероссийский конгресс с международным участием «Нейронауки: интеграция теории и практики», 18-19 ноября 2022 года, Онлайн
P. 37

Russian Military Medical
                ORIGINAL ARTICLES                           Vol. 41 (4) 2022                          Academy Reports
           386
                DOI: https://doi.org/10.17816/rmmar111944
                Research Article
                Effects of human lactoferrin under conditions

                of neurotoxic exposure: experimental research


                Marina Yu. Kopaeva, Anton B. Cherepov, Irina Yu. Zarayskaya
                National Research Center “Kurchatov Institute”, Moscow, Russia
                   BACKGROUND: Translational research using laboratory animals aimed at revealing the features of the pathogenesis of
                Parkinson’s disease serve as a tool for finding new therapeutic strategies.
                   AIM: Was to investigate the effects of human lactoferrin (a multifunctional globular glycoprotein) on behavior the
                1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mice as the model of dopaminergic neurons loss.
                   MATERIALS AND METHODS: Nigrostriatal dopaminergic injury was induced by single administration of 1-methyl-4-phe-
                nyl-1,2,3,6-tetrahydropyridine (40 mg/kg) to five-month-old C57Bl/6 mice. Behavioral functions were assessed in the open
                field and rotarod tests and by the stride length analysis.
                   RESULTS: Preliminary administration of lactoferrin resulted in a significant reduction in the severity of nervous sys-
                tem lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. The positive effect of lactoferrin on the exploratory
                behavior of animals disturbed by neurotoxin, depending on the time of administration, was revealed. Exogenous protein
                with double preliminary administration had a protective effect on the change in body weight of mice after acute 1-methyl-
                4-phenyl-1,2,3,6-tetrahydropyridine exposure. This suggests a reduction in systemic toxic effects against the background
                of lactoferrin therapy.
                   CONCLUSION: The results obtained indicate the possibility of the potential use of lactoferrin as a promising therapeutic
                agent in the treatment of neurodegenerative diseases.
                Keywords: Parkinson’s disease; dopaminergic neurons; exploratory activity; neurodegeneration; neurotoxin MPTP;
                rotarod; open field test; human lactoferrin.

                To cite this article:
                Kopaeva MYu, Cherepov AB, Zarayskaya IYu. Effects of human lactoferrin under conditions of neurotoxic exposure: experimental research.
                Russian Military Medical Academy Reports. 2022;41(4):385–392. DOI: https://doi.org/10.17816/rmmar111944






































                Received: 17.10.2022                      Accepted: 20.10.2022                     Published: 17.11.2022


                                                                                   The article can be used under the CC BY-NC-ND 4.0 license
                                                                                                         © Authors, 2022
   32   33   34   35   36   37   38   39   40   41   42